Recombinant multi-species p300/EP300 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine p300/EP300 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]
The Alternative Names of target: p300, EP300,Histone acetyltransferase p300,p300 HAT,E1A-associated protein p300, Histone butyryltransferase p300, Histone crotonyltransferase p300, Protein 2-hydroxyisobutyryltransferase p300, Protein lactyltransferas p300, Protein propionyltransferase p300,p300,KAT3B,MKHK2,RSTS2

Target products collectionGo to p300/EP300 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T25956-Ab-1/ GM-Tg-hg-T25956-Ab-2 Human p300/EP300 protein Human
GM-Tg-rg-T25956-Ab-1/ GM-Tg-rg-T25956-Ab-2 Rat p300/EP300 protein Rat
GM-Tg-mg-T25956-Ab-1/ GM-Tg-mg-T25956-Ab-2 Mouse p300/EP300 protein Mouse
GM-Tg-cynog-T25956-Ab-1/ GM-Tg-cynog-T25956-Ab-2 Cynomolgus/Rhesus macaque p300/EP300 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-T25956-Ab-1/ GM-Tg-felg-T25956-Ab-2 Feline p300/EP300 protein Feline
GM-Tg-cang-T25956-Ab-1/ GM-Tg-cang-T25956-Ab-2 Canine p300/EP300 protein Canine
GM-Tg-bovg-T25956-Ab-1/ GM-Tg-bovg-T25956-Ab-2 Bovine p300/EP300 protein Bovine
GM-Tg-equg-T25956-Ab-1/ GM-Tg-equg-T25956-Ab-2 Equine p300/EP300 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T25956-Ab-1/ GM-Tg-hg-T25956-Ab-2; GM-Tg-rg-T25956-Ab-1/ GM-Tg-rg-T25956-Ab-2;
GM-Tg-mg-T25956-Ab-1/ GM-Tg-mg-T25956-Ab-2; GM-Tg-cynog-T25956-Ab-1/ GM-Tg-cynog-T25956-Ab-2;
GM-Tg-felg-T25956-Ab-1/ GM-Tg-felg-T25956-Ab-2; GM-Tg-cang-T25956-Ab-1/ GM-Tg-cang-T25956-Ab-2;
GM-Tg-bovg-T25956-Ab-1/ GM-Tg-bovg-T25956-Ab-2; GM-Tg-equg-T25956-Ab-1/ GM-Tg-equg-T25956-Ab-2
Products Name p300/EP300 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name p300/EP300
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine p300/EP300 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.